Arthone's Artica® Oxide Ceramic Femoral Head Receives NMPA Approval, Filling Domestic Gap and Surpassing International Competitors

Smart Medical Device Network News Recently,In a major breakthrough in China's medical technology field, Arthrone Co., Ltd. (hereinafter referred to as Arthrone) announced that its developed zirconia ceramic femoral head product...On January 8, 2025, it obtained certification from the National Medical Products Administration (NMPA), with the registration certificate number being GZXZ 20243132300.

This marks that Arthrone's innovative achievements in the field of high-end medical ceramic materials have officially gained recognition in the Chinese market, filling the gap in the production of high-performance ceramic femoral heads in China and surpassing international competitors in multiple performance indicators.

Arthrone's zirconia ceramic femoral head, named Artica®, is a key component used in hip replacement surgery, specifically designed for patients requiring total hip arthroplasty due to conditions such as avascular necrosis of the femoral head and hip dysplasia.

This product adopts a unique zirconia ceramic material combined with high and low temperature cyclic sintering technology, a process that not only optimizes the microstructure of the material but also enhances its toughness and resistance to breakage while maintaining material strength.

Over the past two decades, Arthrone has been dedicated to the research and development of biomedical materials, particularly the application of high-performance ceramic materials. Zirconia ceramics have become the ideal material for hip joint prostheses due to their excellent chemical inertness and biocompatibility.

Through an innovative high-low temperature sintering process, Arthrone has successfully controlled the phase transformation phenomenon of zirconia ceramics, which typically leads to a decline in material performance during temperature changes. By controlling the ceramic grain size to approximately 200 nanometers, Arthrone has achieved a dual improvement in stability and durability for Artica®.

Phase Transformation Control: Through a unique sintering technology, Arthrone has achieved precise control over the phase transformation of zirconia ceramics, reducing performance degradation caused by phase transformation.

High Toughness and Anti-Fragmentation: The toughness and anti-fragmentation performance of the new generation of zirconia materials are significantly better than those of fourth-generation ceramics (zirconia-toughened alumina ceramics), which means a lower risk of postoperative complications.

Chemical Inertness: Compared with metal femoral heads, the chemical inertness of Artica® reduces the risk of metal ion release, thereby lowering the possibility of prosthesis loosening.

China has more than 500,000 patients each year who require hip replacement surgery, a number that is rising with the aging population. Traditionally, ceramic femoral heads in the market have been primarily supplied by Germany's CeramTec, with these products not only being expensive but also reliant on imports. Arthrone's Artica® has not only broken this technological monopoly but also provided a more economical option.

According to postoperative follow-up data, Artica® achieved a 100% excellent and good rate in Harris scores within 3 years after surgery, and the prosthesis survival rate remained at 100% after 4 years, demonstrating outstanding clinical performance and patient satisfaction.

Arthrone's Artica® surpasses international competitors in multiple performance metrics:

Strength and Durability: The material strength of Artica® surpasses that of similar imported products, ensuring long-term stability and reliability within the patient's body.

Material Toughness: The material exhibits excellent toughness, significantly reducing the risk of postoperative fragmentation and enhancing patient safety.

Surface Finish: Through the self-developed precision machining grinder, the surface finish of the product has reached below 3 nanometers. This extremely high smoothness significantly reduces human wear and tear after implantation and extends the service life of the prosthesis.

Arthrone Co., Ltd. possesses full-industry-chain capabilities from material research and development to product manufacturing, ensuring that every step of the process adheres strictly to high standards. The company owns a series of patented technologies and quality control procedures, guaranteeing that each Artica® meets or exceeds international standards.

Arthrone's innovation not only brings new treatment options to patients in China but also showcases the country’s capabilities in medical technology innovation and manufacturing on a global scale. In the future, Arthrone plans to further expand its product line and continue promoting its high-performance medical ceramic products worldwide. Through broader international cooperation, the company hopes to benefit more patients globally.

Through the success of this product, Arthrone not only promoted the independent innovation of China's medical devices but also set a new benchmark for the global healthcare industry, marking China's advancement to a world-leading level in the field of high-end medical materials.